Prm65 - Different Cost Effectiveness Models Used for Economic Evaluation in Moderate to Severe Painful Diabetic Neuropathy or Post-Herpetic Neuralgia

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psy22 - A Review on Epidemiology, Risk Factors and Treatment Patterns in Moderate and Severe Painful Diabetic Neuropathy and Post-Herpetic Neuralgia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in France: A Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Effectiveness of Different Benfotiamine Dosage Regimens in the Treatment of Painful Diabetic Neuropathy

Arzneimittelforschung
2011English

Painful Diabetic Neuropathy

International Review of Neurobiology
Molecular NeuroscienceNeurologyCellular
2016English

Acupuncture for Painful Diabetic Neuropathy

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Acupuncture for Painful Diabetic Neuropathy

Clinical Neurology
Neurology
2012English

Relief of Post-Herpetic Neuralgia by Surgical Removal of Painful Skin: 5 Years Later

Pain
NeurologyAnesthesiologyPain MedicinePharmacology
2007English

Real-World Treatment of Post-Herpetic Neuralgia With Gabapentin or Pregabalin

Clinical Drug Investigation
MedicinePharmacology
2012English

Gabapentin Versus Tricyclic Antidepressants for Diabetic Neuropathy and Post-Herpetic Neuralgia: Discrepancies Between Direct and Indirect Meta-Analyses of Randomized Controlled Trials

Journal of General Internal Medicine
Internal Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy